Clorox (NYSE:CLX) Price Target Lowered to $139.00 at Evercore ISI

Clorox (NYSE:CLX) had its price objective decreased by Evercore ISI from $140.00 to $139.00 in a research report sent to investors on Monday morning, Benzinga reports. Evercore ISI currently has an underperform rating on the stock.

Several other analysts also recently issued reports on CLX. JPMorgan Chase & Co. raised their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. TD Cowen assumed coverage on Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price on the stock. Barclays lifted their target price on Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $150.14.

Clorox Price Performance

Shares of NYSE CLX opened at $162.61 on Monday. Clorox has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The business has a 50 day moving average price of $158.90 and a two-hundred day moving average price of $145.10. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a market cap of $20.19 billion, a PE ratio of 84.25, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. Sell-side analysts expect that Clorox will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.51% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently bought and sold shares of CLX. Integrated Advisors Network LLC increased its stake in Clorox by 15.1% in the fourth quarter. Integrated Advisors Network LLC now owns 3,338 shares of the company’s stock valued at $476,000 after acquiring an additional 437 shares during the last quarter. Syon Capital LLC bought a new position in Clorox in the fourth quarter valued at approximately $284,000. EP Wealth Advisors LLC increased its stake in Clorox by 4.0% in the fourth quarter. EP Wealth Advisors LLC now owns 6,810 shares of the company’s stock valued at $971,000 after acquiring an additional 263 shares during the last quarter. Richardson Financial Services Inc. bought a new position in Clorox in the fourth quarter valued at approximately $51,000. Finally, Fisher Asset Management LLC increased its stake in Clorox by 2.2% in the fourth quarter. Fisher Asset Management LLC now owns 22,966 shares of the company’s stock valued at $3,275,000 after acquiring an additional 493 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.